2-(2-(2-Ethoxybenzoylamino)-4-chlorophenoxy)-N-(2-ethoxybenzoyl)benzamine inhibits EAT cell induced angiogenesis by down regulation of VEGF secretion

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 10, 2007, Pages 2775-2780

  Priya, B S ^a   Anil Kumar, C ^a   Nanjunda Swamy, S ^a   Basappa, ^a   Naveen, S ^a   Shashidhara Prasad, J ^a   Rangappa, K S ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Amide; Antiangiogenic effect; Benzamine; EAT cell; VEGF

Indexed keywords

2 [2 (2 ETHOXYBENZOYLAMINO) 4 CHLOROPHENOXY] N (2 ETHOXYBENZOYL)BENZAMINE; ANGIOGENESIS INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CRYSTAL STRUCTURE; DOWN REGULATION; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR CELL; MICROWAVE RADIATION; MOUSE; NONHUMAN; PROTEIN SECRETION; X RAY CRYSTALLOGRAPHY;

AMINES; BENZENE DERIVATIVES; DOWN-REGULATION; HUMANS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-BCL-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34247346567     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.02.074     Document Type: Article

References (37)

1. Varner J.A., and Cheresh D.A. In: Hellman S., and Rosenberg S.A. (Eds). DeVita VT. Important Adv. Oncol. Vol. 69 (1996), Lippincott-Raven, Philadelphia
2. Van Hinsbergh V.W.M., Collen A., and Koolwijk P. Ann. Oncol. 10 (1999) 560
3. Hanahan D., and Folkman J. Cell 86 (1996) 353
4. O'Reilly M.S. Invest. New Drugs 15 (1997) 5
5. Kerbel R.S. Carcinogenesis 21 (2000) 505
6. Takayashi Y., Kitadai Y., and Bucana C.D. Cancer Res. 72 (1995) 319
7. Or R., Feferman R., and Shoshan S. Exp. Hematol. 26 (1998) 217
8. Houck K.A., Ferrara N., Winer J., Cachianes G., Philips H.S., and Ferrara N. Nature 362 (1993) 841
9. Ghose A.K., Viswanadhan V.N., and Wendoloski J.J.J. Comb. Chem. 1 (1999) 55
10. Bonnefous C., Vernier J.-M., Hutchinson J.H., Chung J., Reyes-Manalo G., and Kamenecka T. Bioorg. Med. Chem. Lett. 15 (2005) 1197
11. Gududuru V., Hurh E., Dalton J.T., and Miller D.D. Bioorg. Med. Chem. Lett. 14 (2004) 5289
12. Gopalsamy A., Yang H., Ellingboe J.W., Tsou H.-R., Zhang N., Honores E., Powell D., Miranda M., McGinnis J.P., and Rabindran S.K. Bioorg. Med. Chem. Lett. 15 (2005) 1591
13. Priya B.S., Basappa, Nanjunda Swamy S., and Rangappa K.S. Bioorg. Med. Chem. 13 (2005) 2623
14. Kirk K.L., and Filler R. Biomedical Frontiers of Fluorine Chemistry Vol. 3 (1996), Symp. Ser. American Chemical Society, Washington, DC 1
15. Sheehan J.C., and Hess G.D. J. Am. Chem. Soc. 77 (1955) 1067
16. Gelens E., Smeets L., Sliedregt L.A.J.M., van Steen B.J., Kruse C.G., Leurs R., and Orru R.V.A. Tetrahedron Lett. 46 (2005) 3751
17. Lidstorm P., Tierney J., Wathey B., and Westman J. Tetrahedron 57 (2001) 9225
18. Kuhnert N. Angew. Chem., Int. Ed. 41 (2002) 1863
19. Vasquez-Tato M.P. Synlett (1993) 506
20. Perreux L., Loupy A., and Volatron F. Tetrahedron 58 (2002) 2155
21. Abramovitch R.A. Org. Prep. Proc. Int. 23 (1991) 683
22. Caddick S. Tetrahedron 51 (1995) 10403
23. Galema S.A. Chem. Soc. Rev. 26 (1997) 233
24. Loupy A., Petit A., Hamelin J., Texier-Boullet F., Jacquault P., and Mathe D. Synthesis (1998) 1213
25. Varma R.S. Green Chem. (1999) 43
26. Zradni F.-Z., Texier-Boullet F., and Hamelin J. Fifth Int. Electr. Conf. Synth. Org. Chem. (2001) 1
27. Priya B.S., Nanjunda Swamy S., Tejesvi M.V., Basappa, Sarala G., Gaonkar S.L., Naveen S., Shashidhara Prasad J., and Rangappa K.S. Eur. J. Med. Chem. 41 11 (2006) 1262
28. 23
29. Johnson C.K. ORTEP-II, A Fortran Thermal-Ellipsoid Plot Program, Report ORNL-5138 (1976), Oak Ridge National Laboratory, Oak Ridge, TN, USA
30. Otwinowski, G.; Minor, W. Macromolecular Crystallography 1997, 276: part A, 307, Carter, C. M., Jr.; Sweet, R. M., (Eds.), Academic Press.
31. Mackay, S.; Gilmore, C. J.; Edwards, C.; Stewart, N.; Shankland, N. maXus Computer Program for the Solution and Refinement of Crystal Structures, Bruker Nonius, The Netherlands, MacScience, Japan and The University of Glasgow, 1999.
32. Sheldrick, G. M., (SHELXS{97}, SHELXL{97}), University of Gottingen, Germany, 1997.
33. 2 = 0.2136. The hydrogen atoms were placed at chemically acceptable positions and were not included in the refinement. Full crystallographic details have been deposited at the Cambridge Crystallographic Centre.
34. Prabhakar B.T., Khanum S.A., Jayashree K., Salimath B.P., and Shashikanth S. Bioorg. Med. Chem. 14 2 (2006) 435
35. Mahadesh B., and Salimath B.P. Mol. Cell. Biochem. 57 (2005) 273
36. Gururaj A.E., Belakavadi M., Venkatesh D.A., Marmé D., and Salimath B.P. Biochem. Biophys. Res. Comm. 297 (2002) 934
37. 32